Literature DB >> 16220212

A pilot validation study of a new measure of activity in psychosis.

Suzanne Jolley1, Philippa Garety, Graham Dunn, Joanna White, Melissa Aitken, Fiona Challacombe, Mary Griggs, Melissa Wallace, Tom Craig.   

Abstract

BACKGROUND: Wing and Brown [Wing JK and Brown GW (1970) Institutionalism and schizophrenia: a comparative study of three mental health hospitals 1960-1968. Cambridge University Press, London] demonstrated a clear relationship between activity and clinical improvement, using time budget methodology with people with psychosis. However, existing time budget measures are demanding to complete, and simpler, check-box measures of activity rely on subjective frequency judgements and do not include the full range of activities in which an individual might be involved. We report on a pilot validation of a simplified time budget measure of activity levels for routine use as a measure of change with people with psychosis.
METHODS: Forty-two participants living in the local community with a schizophrenia spectrum diagnosis were grouped according to length of illness and, within the longer duration group, into high/low activity. All completed the time budget. On a second occasion, 15 participants also completed the subscales of the Social Functioning Scale (SFS) (Br J Psychiatry 157:853-859, 1990) to assess construct validity, and 15 completed the time budget to assess test-retest reliability.
RESULTS: The time budget discriminated between duration and activity level groups and showed good inter-rater reliability and test-retest reliability. On the SFS, correlations with subscales measuring withdrawal, activities of daily living and employment were found.
CONCLUSIONS: Results indicate that our measure is tapping the activity component of social functioning. A larger scale validation study and investigation of sensitivity to change is underway.

Entities:  

Mesh:

Year:  2005        PMID: 16220212     DOI: 10.1007/s00127-005-0982-x

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  9 in total

1.  The assessment of social adjustment. A review of techniques.

Authors:  M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1975-03

2.  The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients.

Authors:  M Birchwood; J Smith; R Cochrane; S Wetton; S Copestake
Journal:  Br J Psychiatry       Date:  1990-12       Impact factor: 9.319

3.  Social functioning in schizophrenic patients. I. The effects of expressed emotion and family intervention.

Authors:  C Barrowclough; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-05       Impact factor: 4.328

4.  Time use of unemployed and employed single male schizophrenia subjects.

Authors:  R L Hayes; W K Halford
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

5.  Early intervention in schizophrenia.

Authors:  M Birchwood; P McGorry; H Jackson
Journal:  Br J Psychiatry       Date:  1997-01       Impact factor: 9.319

6.  National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome.

Authors:  A Breier; J L Schreiber; J Dyer; D Pickar
Journal:  Arch Gen Psychiatry       Date:  1991-03

7.  A weighted time budget approach for the assessment of cognitive and social activities.

Authors:  R Olbrich; E Voss; L Mussgay; H Pfeiffer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-08       Impact factor: 4.328

8.  Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy.

Authors:  A Gumley; M O'Grady; L McNay; J Reilly; K Power; J Norrie
Journal:  Psychol Med       Date:  2003-04       Impact factor: 7.723

9.  The assessment of social adjustment. An update.

Authors:  M M Weissman; D Sholomskas; K John
Journal:  Arch Gen Psychiatry       Date:  1981-11
  9 in total
  7 in total

1.  A video ethnography approach for linking naturalistic behaviors to research constructs of neurocognition in schizophrenia.

Authors:  Elizabeth Bromley; Gail Fox Adams; John S Brekke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

2.  Understanding reduced activity in psychosis: the roles of stigma and illness appraisals.

Authors:  Anna Moriarty; Suzanne Jolley; Margie M Callanan; Philippa Garety
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-02-25       Impact factor: 4.328

3.  Social networks and support in first-episode psychosis: exploring the role of loneliness and anxiety.

Authors:  Oliver Sündermann; Juliana Onwumere; Fergus Kane; Craig Morgan; Elizabeth Kuipers
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-08-17       Impact factor: 4.328

4.  The Relationship of Motivation and Neurocognition with Functionality in Schizophrenia: A Meta-analytic Review.

Authors:  Antonia Najas-Garcia; Juana Gómez-Benito; Tania B Huedo-Medina
Journal:  Community Ment Health J       Date:  2018-03-31

5.  The Daily Activity Report (DAR) a Novel Measure of Functional Outcome for Serious Mental Illness.

Authors:  Dawn I Velligan; Jim Mintz; Cynthia Sierra; Mona L Martin; Megan Fredrick; Gregory A Maglinte; Patricia K Corey-Lisle
Journal:  Schizophr Bull       Date:  2015-12-27       Impact factor: 9.306

6.  Effectiveness of a social inclusion program in people with non-affective psychosis.

Authors:  Fausto Mazzi; Flavia Baccari; Francesco Mungai; Manuela Ciambellini; Lisa Brescancin; Fabrizio Starace
Journal:  BMC Psychiatry       Date:  2018-06-07       Impact factor: 3.630

7.  The effects of a brief CBT intervention, delivered by frontline mental health staff, to promote recovery in people with psychosis and comorbid anxiety or depression (the GOALS study): study protocol for a randomized controlled trial.

Authors:  Helen Waller; Tom Craig; Sabine Landau; Miriam Fornells-Ambrojo; Nedah Hassanali; Catherine Iredale; Suzanne Jolley; Paul McCrone; Philippa Garety
Journal:  Trials       Date:  2014-06-27       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.